Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: Part I: Comparison with pathologic examination

Investigative Radiology

Volumn 40, Issue 1, 2005, Pages 49-55

  Tae, Hoon Kim ^a   Dong, Hyun Yang ^b   Jin, Woo Choi ^b   Sang, Tae Kim ^b   Jin, Ho Yoon ^b   Ji, Hoon Shin ^b   Joon, Beom Seo ^b   Gyung, Yub Gong ^b   Lim, Tae Hwan ^b,c  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

Animals; Contrast media; Infarction myocardium; Magnetic resonance (MR); Manganese dipyridoxyl diphosphate; Myocardium

Indexed keywords

MANGAFODIPIR; TRIPHENYLTETRAZOLIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; IMAGE QUALITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION INJURY; STUNNED HEART MUSCLE;

EID: 11144292075     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Judd RM, Lugo OC, Aria M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance imaging of 2-day old reperfused canine infarct. Circulation. 1995;92:1902-1910.
2. Vendland MR, Saeed M, Lund G, et al. Contrast-enhanced MRI for quantification of myocardial viability. J Magn Reson Imaging. 1999;10:694-702.
3. Saeed M, Bremerich J, Wendland MF, et al. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology. 1999;213:247-257.
4. Saeed M, Wendland MF, Masui T, et al. Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress. Radiology. 1991;180:153-160.
5. Lim TH, Lee DH, Kim YH, et al. Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement. Radiology. 1993;189:765-768.
6. Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, et al. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest Radiol. 1991;26:969-974.
7. Pislaru SV, Ni Y, Pislaru C, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation. 1999;99:690-696.
8. Choi SI, Choi SH, Kim ST, et al. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model. Radiology. 2000;215:863-868.
9. Marchal G, Ni Y, Herijgers P, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol. 1996;6:2-8.
10. Bremerich J, Saeed M, Arheden H, et al. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model. Radiology. 2000;216:524-530.
11. Brurok H, Ardenkjaer-Larsen JH, Hansson G, et al. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? Biochem Biophys Res Commun. 1999;254:768-772.
12. Jynge P, Brurok H, Asplund A, et al. Cardiovascular safety of MnDPDP and MnC12. Acta Radiol 1997;38:740-749.
13. Hu TC, Pautler RG, MacGowan GA, et al. Manganese-enhanced MRI of mouse heart during changes in inotropy. Magn Reson Med. 2001;46:884-890.
14. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnD-PDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology. 1991;178:73-78.
15. Bernardino ME, Young SW, Lee JKT, et al. Hepatic MR imaging with MnDPDP: safety, image quality, and sensitivity. Radiology. 1992;183:53-58.
16. Wang C, Ahlström H, Ekholm S, et al. Diagnostic efficacy of MnDPDP in MR imaging of the liver: a phase III multicentre study. Acta Radiol. 1997;38:643-649.
17. Wolf GL, Baum L. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. AJR. 1983;141:193-197.
18. Karlsson JOG, Mortensen E, Pedersen HK, et al. Cardiovascular effects of MnDPDP and MnC12 in dogs with acute ischaemic heart failure. Acta Radiol. 1997;38:750-758.
19. Husvedt SO, Grant D, Southon TE, et al. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol. 1997;38:690-699.
20. Karlsson JO, Brurok H, Eriksen M, et al. Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol. 2001;42:540-547.
21. Toft KG, Hustvedt SO, Grant D, et al. Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 1997;38:677-689.
22. Goldman MR, Brady TJ, Pykett IL, et al. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation. 1982;66:1012-1016.
23. Flacke S, Allen JS, Chia JM, et al. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. Radiology. 2003;226:731-738.
24. Wendland MF, Krombach GA, Higgins CB, et al. Contrast enhanced MRI of stunned myocardium using Mn-based MRI contrast media. Acad Radiol. 2002;9:S341-342.
25. Krombach GA, Saeed M, Higgins CB, et al. Contrast-enhanced MR delineation of stunned myocardium with administration of MnCl(2) in rats. Radiology. 2004;230:183-190.
26. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987;21:737-746.
27. Pomeroy OH, Wendland MF, Wagner S, et al. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate: MnDPDP. Invest Radiol. 1989;24:531-536.
28. Saeed M, Wagner S, Wendland MF, et al. Occlusive and reperfused myocardial infarcts: differentiation with MnDPDP-enhanced MR imaging. Radiology. 1989;172:59-64.
29. Wendland MF, Saeed M, Bremerich J, et al. Thallium-like test for myocardial viability with MnDPDP-enhanced MRI. Acad Radiol. 2002;9:82-83.
30. Wyttenbach R, Saeed M, Wendland MF, et al. Detection of acute myocardial ischemia using first-pass dynamics of MnDPDP on inversion recovery echoplanar imaging. J Magn Reson Imaging. 1999;9:209-214.
31. Storey P, Danias PG, Post M, et al. Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart. Invest Radiol. 2003;38:642-652.